Home › Epstein-Barr Virus Infections › Maryland
Pag-aaral pangklinika para sa Epstein-Barr Virus Infections sa Maryland
6 pag-aaral para sa Epstein-Barr Virus Infections ang naghahanap ng mga kalahok sa mga site sa Maryland.
Opisyal na teksto ng pag-aaral (English)
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT03258567Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 29 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06908096Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 1
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05389423A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- National Institutes of Health, Bethesda
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05592626Genetic Studies of Chronic Active Epstein-Barr Disease
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaral
Edad 1 hanggang 120 · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT00032513EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
- Johns Hopkins, Baltimore
Nagre-recruitPhase 2
1 Month – 79 Years · Lahat ng kasarian · Na-update Ago 8, 2025 · NCT03266653Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.